Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. - Wikidata - thesis-toulmin - TriplyDB

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

http://www.wikidata.org/entity/Q34359439

about

Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients Optimal timing for discontinuation of Pneumocystis jiroveci pneumonia prophylaxis in adult patients on highly active antiretroviral therapy (HAART) for HIV infection Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection Artemisinin-based combination therapy for uncomplicated P. falciparum malaria in children with HIV Artemisinin-based combination therapy for uncomplicatedP. falciparummalaria in children with HIV Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness Setting the stage: current state of affairs and major challenges.Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005.18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice.Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study.The burden of common infectious disease syndromes at the clinic and household level from population-based surveillance in rural and urban Kenya Treatment Options for HIV-Associated Tuberculosis.Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.Water filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members.Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia

P2860

Q21032444-5FDB8AEC-BBD5-47D3-BFC7-37A5A327B935 Q21034169-CB9D65F7-E9D8-433D-BE7B-74EE33E1BFA3 Q21133667-44C05BF1-9E6D-425D-B696-B6C0160CE8C4 Q24193204-A7EB1EE9-8016-47D6-93B2-82A456A895E0 Q24203996-A30992EB-C8F8-4821-8FE5-F6F45D8F5319 Q24234778-269969F5-8C3F-4F7C-B5BC-73AC6DB66E37 Q24235145-2FCBD087-A701-4A5C-80A9-6ABF9D0468AA Q26471338-D8DF11E7-A8A0-485C-A908-9154DFEE9ED2 Q27009235-9F67B6B5-B622-420B-80A9-19ADD23B5007 Q28076750-B374CD1F-E57C-42BF-9CD3-6A06073661BF Q28084544-38A0C983-C645-4E41-B100-542A4E593CD3 Q28084902-0EAEA367-31A8-4808-9530-2BCAB71239A3 Q28538874-3319007C-06C9-4BA9-9B22-76AEA6B01C16 Q28552031-1B3EFE24-F98A-4B91-A2FD-CCE9974542DF Q28732123-3D2D64D9-2ED5-4325-A03D-6EBE5F873998 Q28732179-F8BD8A02-1C14-4E1D-9777-A496F7629CF4 Q30388160-863351FD-36D7-42F2-B63E-CE2DB93D9611 Q30424362-921A6EF7-06A6-4C1F-BBEF-C499DF87903F Q30501533-EC496327-90FE-4D40-B583-9079BF2C0C2F Q31122070-E54DCCF1-7529-4C57-9CEE-3C06DE007AEC Q33336235-DA6BACD3-E730-4561-B903-F954F9EF6D57 Q33429719-B4731BC1-1335-4CE1-A215-D2A6770150D3 Q33623400-E1A00707-6966-4AF2-90CF-C1B762885167 Q33634785-AD8D35E1-FAC3-4B36-A5C2-F10172660832 Q33650105-80B61A06-C00D-4F11-B89C-890BE6A6098E Q33725713-3A02A2E8-35B8-4075-BED8-03415663B248 Q33737122-434A958B-B931-4A1C-B72D-E1D25CE2C3F6 Q33757222-DC6C9254-597E-45D1-ACA1-807578F1CB41 Q33793347-748D1DD1-69B8-45BE-823D-F7A2626E0865 Q33793608-EB55378C-E87D-4992-A41A-F57F513AEE65 Q33803895-35F1E729-4813-4E5F-BA7E-610D57A07A98 Q33813097-171069E0-209C-4ED6-BD08-EE69FB3D31C7 Q33817605-66FEA789-4FEC-4907-8E7C-4A140CF81637 Q33834841-48A527DF-C90D-4373-9EB1-0844EB292CDA Q33834900-A4E0A798-0068-4C60-A390-8BDD57A45458 Q33881449-557C721B-40A8-42B3-9D3E-8DE7584A45D2 Q33926411-6437040F-E8EA-45B5-A7B2-4EAF63591F25 Q33973050-0E3F9D3C-2C28-41DA-987E-DDD85EE6CAA5 Q34015894-B0E8C289-5B57-460E-ADFF-385C2F2188A0 Q34108680-D06A284C-7F2A-406A-B65C-1E3682107AC2

P2860

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

http://www.wikidata.org/entity/Q34359439

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@ast

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@en

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@nl

type

label

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@ast

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@en

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@nl

prefLabel

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@ast

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@en

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@nl

P1433

Q34359439-547AEABE-1A49-43BE-80BE-863DFD876E1C

P1476

Q34359439-657BE689-FDC7-4E11-8474-1F40F79B83C7

P2093

Q34359439-19A5FFE5-04D2-4A1D-84E9-9446E214EE75

Q34359439-26CBB494-3C15-47A3-90BC-1392B6D87802

Q34359439-33D5B735-9106-49D7-98D8-EE773D1075D2

Q34359439-46CE59E9-03B5-47F9-A81C-3C9123C5255A

Q34359439-49A2FDB5-AEDD-4883-9BC3-81DF86DA6378

Q34359439-6A669A7D-CE72-446B-8654-3FE284CADA3F

Q34359439-9831FFB8-4039-4C79-A3E6-EF34B752ACE2

Q34359439-9F5C0212-4B50-4ED9-B98A-C9CCEDF1D073

Q34359439-A07D3578-3406-41DF-B408-D6175894115B

Q34359439-A855BCE7-EB8B-4B4C-98A1-213C947BCBB7

P304

Q34359439-769720F7-7F29-45A7-83A0-CE0F1A89B024

P31

Q34359439-34123A61-2221-439C-AB73-E433075970B8

P356

Q34359439-523C1A4B-2EFD-48C9-A579-BF3775D89A80

P407

Q34359439-4D50D593-1F0E-4881-887F-162B7A095E9C

P433

Q34359439-71255E31-75A1-494C-83F0-A3FBA0225807

P478

Q34359439-BACDE224-EE55-4981-8120-8B619A8D3AE3

P50

Q34359439-151840F7-42B9-4744-AD64-4F61402130B6

P577

Q34359439-B558EB43-7C37-494E-B770-C3E3F4A1724C

P698

Q34359439-8DE2D98C-0401-4BC3-AF7B-2B48387A3ACB

P921

Q34359439-76C68EBC-AD0C-409D-9D6C-87AC141BB9A7

Q34359439-C98D636B-082F-42BE-B481-3D7ABF13EA13

P356

S0140-6736(04)17225-5

P1433

P1476

Effect of co-trimoxazole proph ...... HIV infection in rural Uganda.

@en

P2093

Aminah Kigozi

http://www.w3.org/2001/XMLSchema#string

David Culver

http://www.w3.org/2001/XMLSchema#string

Francis Kizito

http://www.w3.org/2001/XMLSchema#string

Frank Kaharuza

http://www.w3.org/2001/XMLSchema#string

John Lule

http://www.w3.org/2001/XMLSchema#string

John Paul Ekwaru

http://www.w3.org/2001/XMLSchema#string

Jonathan Mermin

http://www.w3.org/2001/XMLSchema#string

Ray Ransom

http://www.w3.org/2001/XMLSchema#string

Rebecca Bunnell

http://www.w3.org/2001/XMLSchema#string

Robert Downing

http://www.w3.org/2001/XMLSchema#string

P304

1428-1434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(04)17225-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

9443

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P50

Damalie Nakanjako

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15488218

http://www.w3.org/2001/XMLSchema#string

P921